Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jansen, Floor
RAD-GRIN-201, NCT06392009: Astroscape: a Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients with TSC or FCD Type II	Recruiting	1/2	30	Europe, Canada, RoW	Radiprodil	GRIN Therapeutics, Inc.	Tuberous Sclerosis Complex, Focal Cortical Dysplasia	07/25	07/26
NCT05818943 / 2022-000317-14: Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder	Active, not recruiting	1	24	Europe, Canada, US, RoW	Radiprodil	GRIN Therapeutics, Inc., GRIN Therapeutics, Inc.	GRIN-related Disorders	11/26	11/26